SCHEMBL25919801

SCHEMBL25919801

COc1cc(OC)c2c(c1)C(=O)C(=O)N2C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
MAPT P10636 4/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
LMNA P02545 2/20 0.50
POLB P06746 1/20 0.46
ELANE P08246 2/20 0.44
CYP19A1 P11511 1/20 0.41
NQO2 P16083 1/20 0.41
ACHE P22303 1/20 0.41
PARK7 Q99497 3/20 0.40
KDM4E B2RXH2 1/20 0.40
NPSR1 Q6W5P4 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
MAP2K3 P46734 1/20 0.36
APP P05067 1/20 0.36
CASP3 P42574 1/20 0.36
ESR1 P03372 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25919802 0.79 PARK7 (0.49) ALDH1A1CYP1A2CYP3A4MAPTMEN1
SCHEMBL11201120 0.77 KMT2A (0.61) ALDH1A1MAPTMEN1KMT2ALMNA
SCHEMBL21774714 0.76 CASP1 (0.52) ALDH1A1MAPTMEN1KMT2ALMNA
SCHEMBL1097772 0.72 RAB9A (0.46) ALDH1A1MAPTMEN1KMT2ALMNA
SCHEMBL16226679 0.72 ALDH1A1 (1.00) ALDH1A1CYP1A2CYP3A4MAPTLMNA
SCHEMBL30704878 0.70 CASP3 (0.59) ALDH1A1LMNAPARK7CASP3
SCHEMBL2551295 0.70 CASP3 (0.59) ALDH1A1LMNAPARK7CASP3
SCHEMBL9393324 0.68 ALDH1A1 (0.58) ALDH1A1CYP1A2CYP3A4MAPTMEN1
SCHEMBL30105938 0.68 ALDH1A1 (0.49) ALDH1A1CYP1A2CYP3A4MAPTMEN1
SCHEMBL1095849 0.68 ALDH1A1 (0.45) ALDH1A1MAPTMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230327205-A1 ISATIN DERIVATIVE REDOXAMER FOR ELECTROCHEMICAL DEVICE UCHICAGO ARGONNE, LLC. (US) 2023-10-12 US disclosed
US-20230327205-A1 ISATIN DERIVATIVE REDOXAMER FOR ELECTROCHEMICAL DEVICE UCHICAGO ARGONNE, LLC. (US) 2023-10-12 US disclosed
US-11715844-B2 Isatin derivative redoxmer for electrochemical device UCHICAGO ARGONNE, LLC (US) 2023-08-01 US disclosed
US-11715844-B2 Isatin derivative redoxmer for electrochemical device UCHICAGO ARGONNE, LLC (US) 2023-08-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230327205-A1 ISATIN DERIVATIVE REDOXAMER FOR ELECTROCHEMICAL DEVICE NDUFS5, SQOR, NDUFS7 ALDH1A1 1221/4885CYP1A2 1978/4885CYP3A4 1135/4885
US-11715844-B2 Isatin derivative redoxmer for electrochemical device SQOR, SLC39A14, NDUFS5 ALDH1A1 630/4885CYP1A2 1508/4885CYP3A4 674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.